Jeannot et al. reported that heterozygous germline-inactivating mutations of the CYP1B1 gene might increase the incidence of HCA in women with TCF1 (HNF1A) gene mutations [38]. This evidence concerns the gene HNF1A and hepatocellular adenoma.